Evidence map›Paper›PMID 37670495›Full record

ArticleJournal of diabetes2024

The effects of economic status on metabolic control in type 2 diabetes mellitus at 10 metabolic management centers in China.

Liping Gu, Yuhang Ma, Qidong Zheng, Weiqiong Gu, Tingyu Ke, Li Li, Dong Zhao, Yuancheng Dai, Qijuan Dong, Bangqun Ji and 11 more

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 1 country.

Liping GuDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0003-1975-7057
Yuhang MaDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qidong ZhengDepartment of Internal medicine, The Second People's Hospital of Yuhuan, Yuhuan, China.
Weiqiong GuDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0002-3296-3384
Tingyu KeDepartment of Endocrinology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Li LiDepartment of Endocrinology, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Dong ZhaoCenter for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0002-9847-5439
Yuancheng DaiDepartment of Internal medicine of traditional Chinese medicine, Sheyang Diabetes Hospital, Yancheng, China.
Qijuan DongDepartment of Endocrinology and Metabolism, People's Hospital of Zhengzhou Affiliated Henan University of Chinese Medicine, Zhengzhou, China.
Bangqun JiDepartment of Endocrinology, Xingyi People's Hospital, Xingyi, China.
Fengmei XuDepartment of Endocrinology and Metabolism, Hebi Coal (group). LTD, General hospital, Hebi, China.
Juan ShiDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0003-2652-8084
Ying PengDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0003-1069-7000
Yifei ZhangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0003-0272-0602
Tingting ShenDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Rui DuDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jiaying YangDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Mei KangClinical Research Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yongde PengDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yufan WangDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Weiqing WangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Jiao Tong University · CNAnyang Hospital of Traditional Chinese Medicine · CNBeijing Luhe Hospital Affiliated to Capital Medical University · CNFirst Affiliated Hospital of Henan University · CNHefei Design and Research Institute of Coal Industry (China) · CNKunming Medical University · CNNingbo University · CNState Administration of Foreign Experts Affairs · CN

Funding

China International Medical Foundation 2021-N-03Clinical Research Innovation Plan of Shanghai General Hospital CTCCR-2021C20National Natural Science Foundation of China 81870610Natural Science Foundation of Shanghai 20ZR1444500Shanghai Science and Technology Commission 21Y11904800SHDC SHDC2020CR1001ASHDC SHDC2020CR3065B
6 · The paper itself

Abstract

objectiveThis study investigated the association of economic status with metabolic index control in type 2 diabetes mellitus (T2DM) patients.

methodsIn total, 37 454 T2DM patients from 10 National Metabolic Management Centers in China were recruited and categorized into two groups: a high-gross domestic product (GDP) group (n = 23 993) and a low-GDP group (n = 13 461). Sociodemographic characteristics, medical histories, and lifestyle factors were recorded. Logistic regression and interaction analysis were performed to evaluate the association of economic status and healthy lifestyle with metabolic control.

resultsCompared to the low-GDP group, there were fewer patients with glycated hemoglobin (HbA1c) levels ≥7% in the high-GDP group. Fewer patients with a high GDP had an abnormal metabolic state (HbA1c ≥ 7%, blood pressure [BP] ≥130/80 mm Hg, total cholesterol [TCH] ≥4.5 mmol/L or body mass index [BMI] ≥24 kg/m

conclusionsT2DM patients in economically developed regions had better metabolic control, especially glycemic control. A healthy lifestyle had an additive effect on achieving glycemic goals, even among high-GDP patients.

Indexed as

Diabetes Mellitus, Type 2Blood GlucoseChinaEconomic StatusGlycated HemoglobinHumansBlood GlucoseGlycated Hemoglobinglycosylated hemoglobingross domestic product per capitahealthy lifestylemetabolic management Centretype 2 diabetes mellitus

Identifiers

PMID37670495
PMCPMC10809306
OpenAlexW4386466565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.